Gold price today: Gold is up 0.01% today
The price of gold traded at $2,576.43 per troy ounce, as of 9 a.m. ET. That’s up 0.01% from yesterday’s gold price per ounce ...
Gold price today: Gold is down 0.08% today
The price of gold traded at $2,576.19 per troy ounce, as of 9 a.m. ET. That’s down 0.08% from yesterday’s gold price per ...
Cure Today4d
Antibody-Drug Conjugate Is Tolerable, Active in CLDN6-Positive Solid Tumors Including Ovarian Cancer
Treatment with the antibody-drug conjugate TORL-1-23 was safe and tolerable in heavily pretreated, CLDN6-positive advanced ...
Westside Current on MSN4d
TORL BioTherapeutics Presents Updated Phase 1 Results of Novel Claudin 6 Targeted Antibody-Drug Conjugate TORL-1-23 at the 2024 European Society of Medical Oncology Congress
TORL-1-23 Demonstrates Clinically Meaningful, Durable and Confirmed Responses with a Generally Manageable Safety Profile in Patients with Claudin 6 Positive (CLDN6+) Platinum-Resistant Ovarian Cancer ...
Deccan Herald2d
Central Silk Board to celebrate its Platinum Jubilee in Mysuru on September 20
Mysuru: Central Silk Board (CSB) is all set to celebrate its Platinum Jubilee at the Convocation Hall of Karnataka State Open ...
Interesting Engineering14d
AstroForge plans first-ever private space mission to mine near-Earth asteroid
AstroForge has announced a mission to land on a near-Earth asteroid, marking the first private space mining plan beyond the ...
Westside Current on MSN2d
Innovent Delivers Oral Presentations on Clinical Data of IBI354 (HER2 Monoclonal Antibody-Camptothecin Derivative Conjugate) in Advanced Ovarian Cancer, Breast Cancer and Other ...
SAN FRANCISCO and SUZHOU, China, Sept. 17, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
EurekAlert!13d
Antibody–drug conjugate I-DXd shows clinically meaningful response in patients with extensive-stage small cell lung cancer
The antibody–drug conjugate ifinatamab deruxtecan (I-DXd) showed clinically meaningful responses in pretreated patients with ...
Medscape8d
Novel ADC Shows Promise in Pretreated Extensive SCLC
Patients with pretreated extensive small cell lung cancer could benefit from the antibody-drug conjugate ifinatamab ...
Ascendis to Present First Results from Platinum-Resistant Ovarian Cancer (PROC) Cohort of the Phase 1/2 IL-Believe Trial at ESMO 2024
Anti-tumor clinical responses were observed in 29% (4/14) of efficacy-evaluable patients with PROC treated with TransCon IL-2 β/γ in combination ...
Antibody–drug conjugate I-DXd shows meaningful response in patients with extensive-stage small cell lung cancer
The antibody–drug conjugate ifinatamab deruxtecan (I-DXd) has shown clinically meaningful responses in pretreated patients ...